TeneoBio’s antibody discovery engine is based on UniRat, a proprietary heavy chain only, human immunoglobulin transgenic rat. The firm applies a novel sequence-based discovery approach using NGS, bioinformatics and high-throughput recombinant protein expression. This approach identifies a large set of diverse UniAb leads with broad epitope coverage of target antigens.